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The hepatitis C virus (HCV) nonstructural 5A (NS5A) phosphoprotein has been intensely studied due to its ability to subvert the host interferon-
induced antiviral response. However, more recent studies suggest that it may also play an important regulatory role in HCV RNA replication as well
as modulate host intracellular signaling pathways. Phosphorylation of NS5A appears to be a highly regulated process and several cellular protein
kinases responsible for NS5A phosphorylation have been identified in vitro. Studies utilizing the HCV replicon cell culture system have suggested a
provocative role for the differential phosphorylation of NS5A in the regulation of viral RNA replication through its association with the viral
replication complex, including several host cell factors. Importantly, recent in vivo data linking loss of NS5A hyperphosphorylation to non-
productive HCV replication in the chimpanzee model have provided high validation for targeting the cellular kinases involved, particularly the
kinases responsible for NS5A phosphorylation, for antiviral therapeutic intervention. Understanding the process of NS5A phosphorylation and the
definite identification of the culprit cellular protein kinase(s) will shed light on the mechanisms of HCV RNA replication and/or pathogenesis.
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doi:10.1016/j.virol.2007.01.042RNA genome of HCV codes for a single open reading frame,
resulting in the translation of a single polyprotein of ∼3010
amino acids (aa). The flanking 5′ and 3′ untranslated regions
(UTRs) of the viral RNA genome contain cis-acting signals
important for the initiation of viral RNA translation and
replication (Reed and Rice, 2000). Upon translation, the HCV
polyprotein is processed proteolytically by both cellular and
viral proteases into at least 10 individual proteins, including four
structural proteins (core, E1, E2 and p7) and six nonstructural
(NS) proteins (NS2, NS3, NS4A, NS4B, NS5A, and NS5B)
(Fig. 1). An additional HCV protein, named F (frameshift) has
been recently shown to be produced as a result of a −2/+1
ribosomal frameshift in the N-terminal core (C)-encoding
region, but its role in the HCV lifecycle is not entirely clear.
As the penultimate protein processed from the HCV polyprotein
precursor, NS5A is a proline-rich hydrophilic phosphoprotein
andmay exist as a dimeric form (Tellinghuisen et al., 2005) (for a
recent review of the NS5A protein, see He et al., 2006) (Fig. 1).
Although no intrinsic enzymatic activity has been ascribed to
Fig. 1. Genome organization of HCV and functional structure of the NS5A protein. A schematic representation of the HCV genome indicating the position and
processing of the structural and nonstructural proteins as well as the 5′- and 3′-UTRs, including the internal ribosomal entry site (IRES) and the poly-U-rich ‘X' region,
respectively. The cleavage enzymes are described in the above thick line box. The amino acid positions of NS5A protein are based on HCV genotype 1b (HCV-J). The
three domain structure of NS5A (Tellinghuisen et al., 2004) is depicted. The N-terminal amphipathic α-helix (AH), NS4A-binding site, the IFN-sensitivity-
determining region (ISDR), the class I and class II proline-rich motifs, the variable region V3, and NLS sequences are also shown. In addition, zinc coordination motif,
conserved phosphorylation, basal and hyperphosphorylation sites, as well as caspase-mediates cleavage sites (D2126 and D2361) are noted.
2 MinireviewNS5A, it likely functions through interaction(s) with other HCV
NS proteins and host cell factors. Here, we review our current
understanding of NS5A phosphorylation and the emerging
evidence supporting a model for NS5A phosphorylation-
dependent modulation of HCV RNA replication.
NS5A: a viral Swiss army knife
NS5A first became a focal point of HCV research when it
was reported that mutations within a region of NS5A, termed the
IFN-sensitivity-determining region (ISDR), from HCV geno-
type 1b isolates correlated with the treatment efficacy of IFN-α
(for a historical account on the role of NS5A in confounding
IFN-mediated antiviral responses, see Tan and Katze, 2001).
This finding was important because (i) IFN-α, in combination
with the nucleoside analogue ribavirin, remains the current
standard treatment for HCV infection and (ii) sustained viro-
logical response to the therapy differs substantially among HCV
genotypes in that patients infected with HCV genotypes 2 and 3
generally respond better to IFN-α than those infected with HCV
genotype 1. While the predictive value of the ISDR in patient's
response to IFN therapy has been called into question, this
nevertheless provided the first hint of a potential functional rolefor NS5A. Indeed, subsequent studies have supported the role of
NS5A in counteracting the host IFN response; potential
mechanisms include up-regulation of IL-8 and inhibition of
the IFN-induced dsRNA-dependent protein kinase (PKR) (see
discussion below).
More recently, NS5A has been implicated in the modulation
of host cell cycle, apoptosis, and stress-responsive pathways.
Numerous cellular interacting proteins of NS5A have been
identified, including TATA box binding protein (TBP) (Qadri et
al., 2002), p53 (Lan et al., 2002; Majumder et al., 2001; Qadri
et al., 2002), a novel cellular transcription factor SRCAP (Ghosh
et al., 2000), karyopherin β3 protein (Chung et al., 2000), apo-
liprotein A1 (Shi et al., 2002), and a human vesicle-associated
membrane protein A of 33 kDa (hVAP-A or hVAP-33) (Evans et
al., 2004; Tu et al., 1999), to name a few. Recently, several
laboratories have demonstrated interactions between the proline-
rich motifs (PxxP) in NS5A and the Src homology 3 (SH3)
domains of a variety of proteins involved in signal transduction.
These include growth factor receptor-binding protein 2 (Grb2)
(Tan et al., 1999), the p85 subunit of phosphatidylinositol 3-
kinase (PI3K) (He et al., 2002), Src tyrosine kinases (Macdonald
et al. 2004), Bin-1 (Nanda et al., 2006), and amphiphysin II (Zech
et al., 2003). However, the functional consequences of these
3MinireviewNS5A–host protein–protein interactions during HCV infection
have not been elucidated.
NS5A is localized mostly to the endoplasmic reticulum (ER)
membrane and believed to be a component of the HCV repli-
cation complex comprising NS2 to NS5B, also known as the
replicase. The membrane-anchor region of NS5A has been
mapped to the amino-terminal 30 aa, which contains an am-
phipathic α-helix that is highly preserved among HCV isolates
(Brass et al., 2002). Interestingly, nuclear localization of NS5A
has also been reported (Ide et al., 1996), and caspase-mediated
cleavage products of NS5A, which lack the membrane-anchor
region, are also detected in the nucleus under certain apoptotic
conditions (Goh et al., 2001; Kalamvoki and Mavromara, 2004;
Satoh et al., 2000). Coincidentally, the carboxyl-terminal do-
main of NS5A, including the ISDR, has been shown to exert
potent trans-activating activity, suggesting that NS5A might
function as a viral transcriptional activator (Chung et al., 1997;
Kato et al., 1997; Tanimoto et al., 1997). Moreover, the trans-
criptional activity of NS5A appeared to be affected by mutations
in the ISDR. However, a connection between NS5A transcrip-
tional activity and IFN response has not been demonstrated.
The subcellular localization of NS5A in the HCV replication
compartments suggests that it may play a role in HCV RNA
replication. Furthermore, NS5Awas shown to bind and regulate
the polymerase activity of HCV RNA-dependent RNA poly-
merase, NS5B (Shimakami et al., 2004; Shirota et al., 2002).
Additionally, NS5A has been shown to bind to the 3′-UTR of
HCV plus and minus strand RNAs and may represent a new
class of RNA-binding protein (Huang et al., 2005). In the HCV
replicon systems, cell culture-adapted mutations clustering in
the NS5A region were found to confer higher RNA replication
efficiency (Blight et al., 2000; Guo et al., 2001; Krieger et al.,
2001; Lanford et al., 2003; Lohmann et al., 2003). Interestingly,
some of these mutations affected NS5A phosphorylation, sug-
gesting that phosphorylation may play a role in HCV RNA
replication. In light of these and aforementioned features of
NS5A, the precise roles of the different phospho-forms of NS5A
as well as the identification of the responsible host cell protein
kinases have been the subject of active investigation.
NS5A phosphorylation: a functional role or red herring?
NS5A primarily exists as two phosphorylated forms, mig-
rating as 56 and 58 kDa proteins on SDS-PAGE gels (Kaneko et
al., 1994; Tanji et al., 1995b). The two major phospho-isoforms
are also referred to as basally phosphorylated and hyper-
phosphorylated, respectively. Pulse-chase and mutational ana-
lysis indicate that both the basal and hyperphosphorylation of
NS5A only occur after completion of the proteolytic cleavages at
the N- and C-termini of NS5A, implying that phosphorylation
depends on proper cleavage and/or NS5A protein conformation
(Kaneko et al., 1994; Koch and Bartenschlager, 1999;
Neddermann et al., 1999; Tanji et al., 1995b). In addition, the
association of other HCV NS proteins, including NS4A (Asabe
et al., 1997) and NS2 (Hijikata et al., 1993), may affect the
phosphorylation of NS5A. The NS4A interactive region on
NS5A has been mapped to aa 2135 to 2139 (Asabe et al., 1997).It is likely that a conformational change accompanies NS5A
phosphorylation, which may make it vulnerable to further
phosphorylation by the same or different cellular protein
kinases. These additional phosphorylation events, leading to
the formation of p58, apparently requires the presence of NS3,
NS4A and NS4B (Koch and Bartenschlager, 1999; Neddermann
et al., 1999; Tanji et al., 1995a). While the functional signi-
ficance is not clear, this type of sequential phosphorylation has
been proven significant in the replication of other RNA viruses.
The degree of NS5A phosphorylation does not appear to
determine its localization within the cell as there was no
significant difference noted in the subcellular location of the two
major phospho-isoforms of NS5A (Tanji et al., 1995b). In-
terestingly, the degradation and half-life of the NS5A protein
appear to be affected by phosphorylation; NS5A protein level
has an inverse relationship with its hyperphosphorylation (Piet-
schmann et al., 2001). Finally, the phosphorylation of NS5A is a
conserved trait among divergent HCV isolates, and among other
members of the Flaviviridae (for NS5) (Reed et al., 1998),
suggesting that it may play an important role in the Flavivirus
life cycle. Taken together, these complex patterns and regulation
of NS5A phosphorylation suggest NS5A could have an impor-
tant role in HCV biology.
As mentioned above, some of the cell culture-adapted
mutations in NS5A that render reduced NS5A hyperphosphor-
ylation confer higher RNA replication efficiency in the HCV
replicon system. Consistent with this notion, suppression of
NS5A hyperphosphorylation through either the use of small-
molecule kinase inhibitor (Neddermann et al., 2004) or
mutagenesis studies (Appel et al., 2005) also allowed higher
levels of RNA replication in non-culture-adapted replicons.
However, HCV RNA replication was inhibited when cells
carrying adapted replicons were treated with the same kinase
inhibitor, thus strongly suggesting that NS5A phosphorylation is
an important regulatory mechanism for the viral RNA replication.
Surprisingly, mutations within the region affecting basal
phosphorylation and a deletion removing aa 2380–2409 of
NS5A did not have a significant impact on viral RNA replication
in a replicon system (Appel et al., 2005). It was thus proposed
that perhaps a critical ratio between the p56 and p58 phospho-
forms of NS5A is required for productive HCV RNA replication
(Neddermann et al., 2004). In keeping with this notion, cell-
culture-adaptive mutations known to decrease the level of
hyperphosphorylated NS5A prevented efficient infection of a
full-length RNA in the chimpanzee model (Bukh et al., 2002).
Importantly, these data linking loss of NS5A hyperphosphoryla-
tion to defective HCV replication in vivo arguably provide the
highest validation, in the absence of human or clinical data, for
targeting the cellular kinases responsible for NS5A phosphoryla-
tion for HCV therapy. So, what are the relevant sites of NS5A
phosphorylation and the responsible kinases?
Identification of NS5A basal and hyperphosphorylation
sites
Initial studies focusing on the determination of HCV NS5A
phosphorylation sites have been limited by the lack of an
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recovery of phosphorylated NS5A from HCV-infected liver
cell lysates. Labeling experiments and phosphoamino acid
analysis revealed that NS5A in transfected cells is phosphory-
lated primarily on serine residues and, to a much lesser extent,
threonine residues (Kaneko et al., 1994; Reed et al., 1997;
Tanji et al., 1995b). NS5A deletion mutants indicated that at
least two distinct regions, located around the center and nearby
the carboxyl terminus (residues 2200 to 2250 and 2350 to
2419, respectively) of NS5A (Asabe et al., 1997; Kaneko et
al., 1994; Reed et al., 1997; Tanji et al., 1995b), are required
for basal protein phosphorylation (Fig. 1). Although the
phosphate acceptor sites have not directly been mapped, site-
directed mutagenesis suggested that three serine residues at
positions 2197, 2201 and 2204 (upstream of the ISDR) are
important for hyperphosphorylation of NS5A (Koch and
Bartenschlager, 1999; Tanji et al., 1995b) (Fig. 1). Two of
the serines, S2197 and 2204, when mutated concomitantly in
the HCV replicon system led to reduced NS5A hyperpho-
sphorylation and significantly higher viral RNA levels (Blight
et al., 2000).
In order to map the phosphorylation sites more directly, a
study using recombinantly expressed and purified NS5A com-
bined with two-dimensional (2D) phosphopeptide mapping and
sequencing identified a major phosphorylation site in the HCV
1a genotype NS5A (Reed and Rice, 1999). However, the
phosphorylation site, Ser-2321, is not conserved across HCV
genotypes. Using a different approach that combines 2D phos-
phopeptide mapping and electrospray ionization mass spectro-
metry, another group identified Ser-2194 as a predominant
phosphorylation site in the NS5A protein derived from HCV 1b
genotype (Katze et al., 2000). Both Ser-2194 and the phos-
phopeptide sequence containing Ser-2194, which spans NS5A
residues GSPPSLASSSASQLSAPSLK, are highly conserved
across HCV genotypes. However, since both studies used non-
hepatocyte-derived cell lines as a source of mammalian protein
kinases, it will be critical to determine the relevance of
phosphorylation of Ser-2321 or/and Ser-2194 in HCV RNA
replication in the natural host cell.Table 1
Summary of properties of NS5A-associated protein kinase(s) (adapted from Reed et
pH Neutral or slightly alkaline
Divalent cation concentration 10 mM Mn2+ or 2.5 mM Mg2+ (Mn2+>Mg
Temperature and length of incubation 37 °C, 2 h or 30 °C 4 h
Candidates (serine/threonine
protein kinases)
CKII, CDKs, MAPKs, GSK3, MEK1, MEK
Inhibitors tested Name Bisindolyl male
I–HCl
In vitro Concentration d 1 μM
Inhibition –
In vivo Concentration d 10 μM
Inhibition –
N/A, not tested.
a N-[2-(p-bromocinnamyl-amino) ethyl]-5-isoquinoline-sulfonamide dihydrochlor
b 5,6-Dichloro-1-β-D-ribofuranosyl benzimidazol.
c N-(2-aminoethyl)-5-chloronaphthalene-1-sulfonamide.
d Maximum concentration tested.The search for NS5A-associated protein kinases
In studies utilizing chemical inhibitors of protein kinases,
the kinase(s) associated with the NS5 protein of other Flavi-
viruses, including dengue virus type-2 (DEN-2), tick-borne
encephalitis virus, Yellow Fever virus (YF), and the NS5A
protein of the Pestivirus bovine viral diarrhea virus (BVDV) all
displayed similar inhibition profiles (Reed et al., 1998). These
similarities further suggest that these viral proteins are phos-
phorylated by one or more related cellular serine/threonine
kinases. The properties of the NS5A-associated protein kinase
(s) are summarized in Table 1.
Highly purified preparations of NS5A protein derived
from HCV genotype 1b were phosphorylated efficiently when
subjected to an in vitro protein kinase assay (Katze et al.,
2000). This is consistent with previous reports that NS5A is
associated tightly with a cellular protein kinase(s) (Ide et al.,
1997). Host cell transcription does not appear to be necessary
for NS5A phosphorylation since NS5A phosphorylation in
transfected cells can occur in the presence of actinomycin D.
Phosphorylation of NS5A in vitro reaches the highest level
when the pH of the reaction is neutral or slightly alkaline.
Interestingly, the NS5A-associated kinase activity has an
unusual preference for Mn2+ over Mg2+, is inhibited by the
addition of Ca2+, and appears somewhat resistant to the
general protein kinase inhibitor staurosporine (Reed et al.,
1997). The IFN-induced PKR protein kinase would fit these
criteria as the putative NS5A-specific kinase. As previously
mentioned, NS5A has been shown to confer viral resistance
to IFN, possibly through its association with PKR via the
ISDR region of NS5A. This sequence contains two of three
serine residues which contribute significantly to the hyper-
phosphorylation of NS5A (Tanji et al., 1995b). However,
phosphorylation of NS5A by purified PKR was not observed
in vitro (Gale et al., 1997) nor was it stimulated by PKR
activators such as dsRNA and heparin (Reed and Rice,
1999). In addition, NS5A with mutation of Ser-2194 to
alanine retained the ability to interact with PKR (Katze et al.,
2000).al., 1997)
2+)
6, MEK7, AKT, p70S6K, and CKI
imide Olomoucine H-89 a DRBb Hypericin A-3 c Staurosporine
1 mM 10 μM 100 μM 1 μM 200 μM 10 nM
73% – 67% <25% <25% <30%
1 mM 10 μM 100 μM N/A N/A 1 μM
+(36%) ±(9%) – N/A N/A +(22%)
ide.
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NS5A phosphorylation has suggested that the protein kinase
responsible for the basal NS5A phosphorylation may be a
member of the CMGC family, which includes CKII and proline-
directed kinases such as the cyclin-dependent kinases (CDKs),
mitogen-activated protein kinases (MAPKs), and glycogen
synthase kinase 3 (GSK3) (Reed et al., 1997). The nature of the
aa sequence flanking the phospho-site Ser-2321 would support
a role for a proline-directed kinase in HCV NS5A basal
phosphorylation (Reed and Rice, 1999). NS5A in fact contains
several phosphorylation sequence motifs (–[SP]–) for proline-
directed protein kinases such as CDKs and MAPKs. In this
regard, it is interesting that NS5A has been implicated in
modulating MAPK signaling (He and Katze, 2002; Tan et al.,
1999) and cell cycle control (Arima et al., 2001; Ghosh et al.,
1999). With respect to CKII, it is noteworthy that this protein
kinase has been shown to bind to the C-terminal portion of
NS5A and phosphorylate it in vitro (Kim et al., 1999).
However, it is not known whether CKII phosphorylates the
sites previously identified on NS5A. Furthermore, deletion of
all of potential CKII phosphorylation sites in NS5A (Huang et
al., 2005) and small-molecule inhibition of CKII (Huang et al.,
2006) did not significantly affect HCV RNA replication in
replicon systems.
In another approach, Coito et al. (2004) screened 119
recombinant yeast serine/threonine protein kinases for their
abilities to phosphorylate NS5A in vitro. In addition to
confirming CKII as a potential NS5A kinase, several human
counterparts of the identified yeast kinases, namely MEK1,
MEK6, MEK7, AKT, p70S6K, and CKI were also found to be
capable of phosphorylating NS5A in this study (Table 1).
Notably, CKI was recently found to have a critical role in the
hyperphosphorylation of NS5A in human hepatoma cell lines
(see below). While follow-up experiments will be required to
ascertain whether any other of these candidate kinases can
phosphorylate NS5A in human liver cells, the identification of
MEK family kinases supports a recent study that a protein
kinase(s) in the Ras-MAPK pathway is involved in NS5A
phosphorylation-dependent HCV RNA replication (Huang et
al., 2006). Intriguingly, inhibition of MEK1/2 by small-
molecule inhibitors also led to enhanced HCV replication, in
line with the previously mentioned findings that suppression of
NS5A hyperphosphorylation confers higher levels of HCV
RNA replication. However, inhibition of MEK1/2 kinase
activity did not lead to complete abrogation of NS5A
phosphorylation, suggesting that basal phosphorylation of
NS5A is carried by another protein kinase(s).
More recently, Quintavalle et al. (2006) used kinase inhibitors
that specifically inhibit NS5A hyperphosphorylation to inves-
tigate which cellular kinases were specifically implicated in the
formation of the NS5A p58 phospho-isoform. The CKI protein
kinase family was thus identified as a major determinant of
NS5A hyperphosphorylation. Interestingly, overexpression of
either CKI-α, CKI-δ or CKI-ε gave rise to increased p58 levels
in cultured hepatoma cells. Conversely, RNA interference of
only CKI-α reduced NS5A hyperphosphorylation and rescue of
inhibition of p58 formation was specifically achieved by CKI-α.Although there is a possibility that NS5A is not a direct substrate
of CKI and an enzyme downstream of CKI may be responsible
for NS5A modification, the region around the putative NS5A
hyperphosphorylation contains more than one consensus
sequence for CKI recognition, suggesting that one or more of
the serine residues situated in this region might indeed be a
substrate for CKI. Indeed, NS5Awas subsequently confirmed to
be a direct substrate of CKI-α (Quintavalle et al., 2007), and thus
may be one of the long-sought enzymes responsible for the
hyperphosphorylation of NS5A and a potential drug target for
anti-HCV therapy. It will be important to examine whether
hyperphosphorylation of NS5A by CKI-α could modulate
binding of NS5A to host cell proteins such as hVAP-A, which is
critical for the formation of HCV replicase and viral RNA
synthesis on ERmembranes (see below). Antagonism of CKI-α,
however, may pose potential tumorigenesis risk due to the
negative role that it normally plays on the Wnt and Hedgehog
signaling (Price, 2006).
An emerging model for NS5A-dependent modulation of
HCV RNA replication
So how might differential phosphorylation of NS5A control
HCV RNA replication? Both unphosphorylated and phosphory-
lated derivatives of NS5A appear to bind NS5B equally well
(Huang et al., 2005), suggesting an indirect mechanism. A clue
was provided by the finding that NS5A (as well as NS5B) can
associate with the SNARE-like membrane protein hVAP-A via
the region of NS5A involved in hyperphosphorylation (Tu et al.,
1999). hVAP-A is a widely expressed, ER/Golgi-localized
protein involved in intracellular vesicle trafficking. NS5A and
NS5B bind different domains of hVAP-A, with NS5A binding to
the C-terminus, and NS5B binding to the N-terminus of the
cellular protein. Thus, hVAP-A could serve as a docking site for
assembly and/or localization of HCV replicase on intracellular
membranes. Consistent with the hypothesis, these three proteins
colocalize significantly in cells, especially within the detergent-
resistant membrane fraction or lipid rafts, the subcellular
structure where HCV replicase is presumably located. Impor-
tantly, hVAP-A is critical for HCV RNA replication; expression
of truncated, dominant-negative mutants or siRNA of hVAP-A
decreased both HCV RNA and protein levels in HCV replicon
cells (Gao et al., 2004). Finally, NS5A mutations that blocked
interaction with hVAP-A also strongly reduced HCV RNA
replication (Evans et al., 2004).
Intriguingly, a subset of the previously identified adaptive
mutations suppressing NS5A hyperphosphorylation displayed
increased binding capacity to hVAP-A (Evans et al., 2004). This
inverse relationship between NS5A hyperphosphorylation and
interaction with hVAP-A led the investigators to propose a
model (Fig. 2). Basally phosphorylated NS5A normally binds
hVAP-A which in turn may facilitate or stabilize NS5A inter-
action with NS5B to regulate its polymerase activity. Hyperpho-
sphorylation of NS5A prevents its binding to hVAP-A,
disrupting the replicase complex and hence preventing viral
RNA replication. Thus, NS5A phosphorylation likely functions
as a regulatory switch by modulating the interaction of NS5A
Fig. 2. Model describing of the role of NS5A kinase(s) in modulating HCV RNA replication. Schematic depicting the role of NS5A phosphorylation and its interaction
with hVAP-A. NS5A is localized mostly to the ER membrane and is a part of HCV replicase, a multi-component replication complex comprising NS2 to NS5B and
host cell factors. Basally phosphorylated NS5A binds hVAP-Awhich in turn may facilitate or stabilize NS5A interaction with NS5B to regulate its polymerase activity.
Hyperphosphorylation prevents NS5A binding to hVAP-A, resulting in a disruption of the replicase complex and hence decreased viral RNA replication. Other
possible functions for NS5A phosphorylation may include regulation of HCV nonstructural (NS) polypeptide processing, IRES-mediated translation and/or viral RNA
packaging. Model is derived from Evans et al. (2004) and Gao et al. (2004).
6 Minireviewwith other host/viral components of the HCV replicase
complex.
This picture, of course, is far from complete. If hyperpho-
sphorylation of NS5A does indeed regulate viral RNA repli-
cation, one would predict the existence of extracellular and
intracellular stimuli that are capable of altering the levels of
NS5A hyperphosphorylation. In this regard, it is interesting
that inhibition of basally activated Ras-MAPK pathway was
sufficient to promote HCV RNA replication, whereas activa-
tion of the pathway suppressed viral RNA replication in a
replicon system (Huang et al., 2006). Further analysis suggests
that a Ras-MAPK pathway may normally serve to negatively
control HCV RNA replication, at least in part through a direct
or indirect modulation of NS5A protein phosphorylation.
Moreover, HCV has been shown to possess mechanisms to
down-modulate the MAPK signaling pathway (Tan et al., 1999;
Macdonald et al., 2003, 2005), which includes NS5A
interaction with upstream adaptor protein Grb2 (Tan et al.,
1999) and Src tyrosine kinases (Macdonald et al., 2004). It is
thus tempting to speculate that one function of non- or basally
phosphorylated NS5A is to keep MAPK activation in check by
binding to and sequestering/inhibiting Grb2 and/or Src kinases
to allow HCV RNA replication. Activation of the Ras-MAPK
pathway by external stimuli would disrupt this regulation
through the induction of NS5A hyperphosphorylation and thus
subsequent inhibition of viral RNA replication in cell culture.
However, it is not known if the Grb2-NS5A interaction is
influenced by NS5A phosphorylation or whether the PxxPmotifs of NS5A act as docking sites for SH3 domain-containing
protein kinases.
Concluding remarks and future studies
Recent studies in the HCV replicon cell culture systems have
suggested an important role for NS5A phosphorylation in HCV
RNA replication. The major phosphorylation sites and several
candidates of the responsible host cell kinases have been
identified. However, since they were identified from in vitro
replication systems and thus may be vulnerable to cell culture-
adapted artifacts, they must be validated in the context of the
complete viral life cycle using the recently developed infectious
HCV cell culture systems (Lindenbach et al., 2005; Wakita et
al., 2005; Zhong et al., 2005) as well as surrogate models such
as DEN-2, YF and BVDV, and ultimately in the chimpanzee
model (Table 2). Importantly, NS5A hyperphosphorylation
appears to play different roles between in vitro and in vivo
systems (Bukh et al., 2002) and the degree and requirements for
hyperphosphorylation may vary between different HCV geno-
types and isolates. It is also possible that NS5A phosphorylation
contributes to a switch between viral RNA replication vs. RNA
translation and/or packaging. The latter might also explain why
hyperphosphorylation of NS5A is actively selected against in
replicon-based systems. In this regard, a possible role for NS5A
phosphorylation in modulating NS5A binding to the 3′ ends of
HCV plus- and minus-strand RNAs (Huang et al., 2005) and
modulation of IRES-dependent translation (He et al., 2003;
Table 2
Summary of reported NS5A mutations affecting HCV RNA replication
Mutation HCV replicon RNA
replication
HCV infectivity in
chimpanzees
Notes
T1993A N/A N/A Mutation was detected in infected chimpanzee (Thomson et al., 2001)
M2105V N/A N/A Mutation was detected in infected chimpanzee (Thomson et al., 2001)
T2185A (genotype 1a) ↓ (Evans et al., 2004) N/A A2185T (genotype 1b), ↑ hVAP-A binding (Evans et al., 2004)
K2187G (genotype 1a) ↓ (Evans et al., 2004) N/A G2187K (genotype 1b), ↑ hVAP-A binding (Evans et al., 2004)
S2197P (S1172) ↑ (Blight et al., 2000) ↓ (Bukh et al., 2002) ↓ NS5A hyperphosphorylation (Blight et al., 2000)
A2199T ↑ (Blight et al., 2000) N/A No effect on hVAP-A binding (Evans et al., 2004)
S2204 (S1179) I/R ↑ (Blight et al., 2000) N/A ↓ NS5A hyperphosphorylation (Blight et al., 2000),
modulate hVAP-A binding (Evans et al., 2004)
P2209L ↑ (Kohashi et al., 2006) N/A Within ISDR, ↑ IFN response in patients (Watanabe et al., 2001)
Q2218H ↓ (Kohashi et al., 2006) N/A Most frequently detected within ISDR in patients (Watanabe et al., 2001)
E2356G N/A N/A Mutation was detected in infected chimpanzee (Bukh et al., 2002)
S2362N N/A N/A Mutation was detected in infected chimpanzee (Bukh et al., 2002)
D2375G N/A N/A Mutation was detected in infected chimpanzee (Bukh et al., 2002)
7MinireviewKalliampakou et al., 2005; Wang et al., 2003) has not been
examined.
In addition, the questions as to how phosphorylation of
NS5A affects its association with HCV NS4A, NS5B or ER
membrane, NS5A dimerization, as well as its interactions with
the plethora of host proteins need to be systematically
addressed. While further understanding of the biology of
NS5A phosphorylation will require further characterization of
the protein kinases and phosphate acceptor sites involved in
NS5A phosphorylation, it should be kept in mind that the
association with NS5A with host cell kinases may in turn
affect the physiological function of these kinases. In fact,
NS5A can bind the PI3K kinase, and the interaction seems to
stimulate the PI3K-AKT pathway, which would suppress
cellular apoptosis, allowing viral persistence and/or malignant
transformation (He et al., 2002; Street et al., 2004). In a more
recent study, NS5A was found to interact with Raf-1 and the
kinase activity was increased in NS5A-expressing or HCV
replicon cells (Burckstummer et al., 2006). However, phos-
phorylation of NS5A by Raf-1 was not demonstrated in the
study. Finally, CK1-α is known to regulate RNA-binding
property of hnRNP C proteins (Kattapuram et al., 2005),
which have been reported to bind the 3′-UTR of HCV genome
(Gontarek et al., 1999). It may be interesting to examine
whether the kinase activity of CK1α itself is modulated by
NS5A as a potential mechanism by which NS5A regulates
HCV RNA replication.
For many small RNA viruses such as HCV, it is imperative
that their genomes encode proteins that are capable of
performing more than one function, perhaps at different stages
during the viral lifecycle and when necessary, depending on
host cell biology. Phosphorylation (as well as other post-
translational modifications) of a viral protein such as NS5A by a
host cell protein kinase(s) to produce different biological
functions is thus a clever and economic strategy. Understanding
the process of NS5A phosphorylation, including the yet-to-be-
identified cellular protein phosphatase(s) of NS5A, and its role
in the HCV life cycle will not only reveal mechanisms of HCV
RNA replication and/or pathogenesis but may also provide new
avenues for the therapeutic intervention.Acknowledgments
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